JP2000504579A5 - - Google Patents

Download PDF

Info

Publication number
JP2000504579A5
JP2000504579A5 JP1997528984A JP52898497A JP2000504579A5 JP 2000504579 A5 JP2000504579 A5 JP 2000504579A5 JP 1997528984 A JP1997528984 A JP 1997528984A JP 52898497 A JP52898497 A JP 52898497A JP 2000504579 A5 JP2000504579 A5 JP 2000504579A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1997528984A
Other languages
English (en)
Other versions
JP2000504579A (ja
Filing date
Publication date
Priority claimed from DE19605548A external-priority patent/DE19605548A1/de
Application filed filed Critical
Publication of JP2000504579A publication Critical patent/JP2000504579A/ja
Publication of JP2000504579A5 publication Critical patent/JP2000504579A5/ja
Abandoned legal-status Critical Current

Links

Description

Figure 2000504579
Figure 2000504579
Figure 2000504579
Figure 2000504579
JP9528984A 1996-02-15 1997-02-13 高等真核細胞の形質移入のための組成物 Abandoned JP2000504579A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19605548A DE19605548A1 (de) 1996-02-15 1996-02-15 Zusammensetzung für die Transfektion höherer eukaryotischer Zellen
DE19605548.2 1996-02-15
PCT/EP1997/000649 WO1997030170A1 (de) 1996-02-15 1997-02-13 Zusammensetzung für die transfektion höherer eukaryotischer zellen

Publications (2)

Publication Number Publication Date
JP2000504579A JP2000504579A (ja) 2000-04-18
JP2000504579A5 true JP2000504579A5 (ja) 2004-11-18

Family

ID=7785445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9528984A Abandoned JP2000504579A (ja) 1996-02-15 1997-02-13 高等真核細胞の形質移入のための組成物

Country Status (6)

Country Link
EP (1) EP0900281A1 (ja)
JP (1) JP2000504579A (ja)
CA (1) CA2246227A1 (ja)
DE (1) DE19605548A1 (ja)
MX (1) MX9805507A (ja)
WO (1) WO1997030170A1 (ja)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2766706B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Sa Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation
FR2766705B1 (fr) * 1997-07-30 2001-05-25 Biovector Therapeutics Complexe particulaire de charge globale neutre ou negative forme d'une vesicule cationique ou neutre et d'une substance biologiquement active anionique, leur preparation et leur utilisation
GB9918670D0 (en) 1999-08-06 1999-10-13 Celltech Therapeutics Ltd Biological product
GB0120022D0 (en) * 2001-08-16 2001-10-10 Photobiotics Ltd Conjugate
HUE026646T2 (en) 2010-07-06 2016-07-28 Glaxosmithkline Biologicals Sa Preferred liposomes containing lipids of PKA value for delivery of RNA
PL2591114T3 (pl) 2010-07-06 2017-08-31 Glaxosmithkline Biologicals Sa Immunizacja dużych ssaków małymi dawkami rna
HUE047796T2 (hu) 2010-07-06 2020-05-28 Glaxosmithkline Biologicals Sa RNS bevitele több immunútvonal bekapcsolására
PT3970742T (pt) 2010-08-31 2022-06-27 Glaxosmithkline Biologicals Sa Lipossomas peguilados para entrega de arn codificador de imunogénio
JP2013544504A (ja) 2010-10-11 2013-12-19 ノバルティス アーゲー 抗原送達プラットフォーム
WO2013006838A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
US20140141070A1 (en) 2011-07-06 2014-05-22 Andrew Geall Liposomes having useful n:p ratio for delivery of rna molecules
WO2013051718A1 (ja) 2011-10-07 2013-04-11 国立大学法人三重大学 キメラ抗原受容体
WO2017024318A1 (en) 2015-08-06 2017-02-09 Dana-Farber Cancer Institute, Inc. Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
US11052111B2 (en) 2015-12-08 2021-07-06 Chimera Bioengineering, Inc. Smart CAR devices and DE CAR polypeptides for treating disease and methods for enhancing immune responses
EP4342978A3 (en) 2016-09-01 2024-07-03 Chimera Bioengineering Inc. Gold optimized car t-cells
EP3580212A4 (en) 2017-02-08 2021-03-17 Dana Farber Cancer Institute, Inc. REGULATION OF CHEMERIC ANTIGEN RECEPTORS
EP3790896A1 (en) 2018-05-07 2021-03-17 Children's Hospital Medical Center Chimeric polypeptides, nucleic acid molecules, cells, and related methods
AU2020257748A1 (en) 2019-04-19 2021-11-18 Chugai Seiyaku Kabushiki Kaisha Chimeric receptor recognizing modification site of antibody
JPWO2020246563A1 (ja) 2019-06-05 2020-12-10
CN116194124A (zh) 2020-07-31 2023-05-30 中外制药株式会社 包含表达嵌合受体的细胞的药物组合物
WO2022196719A1 (ja) 2021-03-17 2022-09-22 第一三共株式会社 抗アセチルコリン受容体自己抗体に対するキメラ受容体をコードする遺伝子
US20240366666A1 (en) 2021-04-08 2024-11-07 Phosphogam, Llc Methods and compositions for enhancing the cytotoxicity of gamma/delta-t cells
JPWO2024150525A1 (ja) 2023-01-12 2024-07-18

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
WO1995002698A1 (en) * 1993-07-12 1995-01-26 Life Technologies, Inc. Composition and methods for transfecting eukaryotic cells
FR2714830B1 (fr) * 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
US5928944A (en) * 1994-02-04 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method of adenoviral-medicated cell transfection
US5736392A (en) * 1995-06-07 1998-04-07 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
IL115199A (en) * 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition

Similar Documents

Publication Publication Date Title
JP2000502280A5 (ja)
JP2000501771A5 (ja)
JP2000501599A5 (ja)
JP2001506266A5 (ja)
JP2000500076A5 (ja)
JP2001504398A5 (ja)
JP2000501324A5 (ja)
JP2000500055A5 (ja)
JP2000500026A5 (ja)
JP2000502472A5 (ja)
JP2000501825A5 (ja)
JP2000500874A5 (ja)
JP2000514722A5 (ja)
JP2000502485A5 (ja)
JP2000502425A5 (ja)
JP2000516811A5 (ja)
JP2000502568A5 (ja)
JP2000501774A5 (ja)
JP2000500912A5 (ja)
JP2000502570A5 (ja)
JP2000501876A5 (ja)
JP2000513361A5 (ja)
JP2000501744A5 (ja)
JP2000500857A5 (ja)
JP2000502316A5 (ja)